E88.41 ICD-10-CM Code: MELAS syndrome
E88.41 is not a CMS-HCC payment code. MEAT criteria · RAF Calculator · HCC coding software
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Endocrine, nutritional and metabolic diseases (E00-E89) / Metabolic disorders (E70-E88)
E88.41
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceMELAS syndrome
MELAS syndrome is a rare inherited neurological disorder characterized by stroke-like episodes, seizures, and progressive brain dysfunction that typically begins in childhood. The condition affects the mitochondria (the energy-producing parts of cells), leading to inadequate oxygen supply to the brain and muscles.

Buddy Insight
MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes) syndrome is a specific mitochondrial disorder characterized by recurrent stroke-like episodes, seizures, lactic acidosis, and progressive neurological decline.
CMS-HCC V28
N/A—
Not mapped
CMS-HCC V24
HistoricalHistorical
Not used for CY2026 payment
ACA/HHS
Context neededHCC 028
Coefficient needs member context
ESRD/PACE
Context neededHCC 23
Coefficient needs member context
RXHCC
MappedHCC 43
Code-level coefficient reference
Code Book Path
Inclusion Terms
Official- Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes
Excludes 2
Official- Ehlers-Danlos syndromes (Q79.6-)Inherited from E70-E88
Related Codes
Includes
OfficialNo Includes notes are included in this display for E88.41. Check the code and parent instructions in the Code Book.
Excludes 1
Official- transitory endocrine and metabolic disorders specific to newborn (P70-P74)Inherited from E00-E89, E70-E88, E88, E88.4
- androgen insensitivity syndrome (E34.5-)Inherited from E00-E89, E70-E88, E88, E88.4
- congenital adrenal hyperplasia (E25.0)Inherited from E00-E89, E70-E88, E88, E88.4
- hemolytic anemias attributable to enzyme disorders (D55.-)Inherited from E00-E89, E70-E88, E88, E88.4
- Marfan syndrome (Q87.4-)Inherited from E00-E89, E70-E88, E88, E88.4
- 5-alpha-reductase deficiency (E29.1)Inherited from E00-E89, E70-E88, E88, E88.4
- histiocytosis X (chronic) (C96.6)Inherited from E00-E89, E70-E88, E88, E88.4
- disorders of pyruvate metabolism (E74.4)Inherited from E00-E89, E70-E88, E88, E88.4
- Kearns-Sayre syndrome (H49.81)Inherited from E00-E89, E70-E88, E88, E88.4
- Leber's disease (H47.22)Inherited from E00-E89, E70-E88, E88, E88.4
- Leigh's encephalopathy (G31.82)Inherited from E00-E89, E70-E88, E88, E88.4
- Mitochondrial myopathy, NEC (G71.3)Inherited from E00-E89, E70-E88, E88, E88.4
- Reye's syndrome (G93.7)Inherited from E00-E89, E70-E88, E88, E88.4
Code First
OfficialNo Code First sequencing instructions are included in this display for E88.41. Check the code and parent instructions in the Code Book.
Use Additional
Official- codes for associated conditionsInherited from E88
Code Also
OfficialNo Code Also instructions are included in this display for E88.41. Check the code and parent instructions in the Code Book.
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →
Is E88.41 an HCC code?
E88.41 is not in the CMS-HCC V28 or V24 community payment model. E88.41 has a separate mapping under the CMS-HCC ESRD model (HCC 23 (Other Significant Endocrine and Metabolic Disorders)) and the Part D RxHCC model (HCC 43 (Pituitary, Adrenal Gland, and Other Endocrine and Metabolic Disorders)); the applicable result needs member context. E88.41 also appears in the HHS-HCC commercial risk model (HCC 028 (HHS-HCC 028 child, RAF varies by metal level)), where the result depends on member context and is not a Medicare Advantage payment mapping.
- Code
- E88.41
- Description
- MELAS syndrome
- HCC (V28)
- No CMS-HCC V28 mapping
- RAF reference coefficient
- —
- Billable
- Yes
- Payment year
- 2026
HCC Category Mapping
These are source-labeled model coefficients, not member totals. A category may still be removed by hierarchy or model cleanup rules. Weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member context, hierarchy and cleanup rules, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains available for historical review.
Work E88.41 in the Code Book — tabular path, V28 RAF reference, and MEAT checklist →
MEAT review for E88.41
For E88.41, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Coder workflow notes
Get the V28 mapping + MEAT cheat sheet
One printable reference: check representative V28 mappings and the documentation reminders your note needs. Free, no card.
Free PDF. No card. Unsubscribe anytime.
What This Code Means
E88.41 is the ICD-10-CM diagnosis code for melas syndrome. MELAS syndrome is a rare inherited neurological disorder characterized by stroke-like episodes, seizures, and progressive brain dysfunction that typically begins in childhood. The condition affects the mitochondria (the energy-producing parts of cells), leading to inadequate oxygen supply to the brain and muscles. E88.41 sits in the ICD-10-CM chapter for endocrine, nutritional and metabolic diseases (e00-e89), within the section covering metabolic disorders (e70-e88).
E88.41 has no mapping under the CMS-HCC V28 or V24 community payment models. E88.41 has a separate mapping under the CMS-HCC ESRD model (HCC 23 (Other Significant Endocrine and Metabolic Disorders)) and the Part D RxHCC model (HCC 43 (Pituitary, Adrenal Gland, and Other Endocrine and Metabolic Disorders)); the applicable result needs member context. E88.41 also appears in the HHS-HCC commercial risk model (HCC 028 (HHS-HCC 028 child, RAF varies by metal level)), where the result depends on member context and is not a Medicare Advantage payment mapping. Do not assign V28 risk adjustment value from this page; verify the applicable model and payment year before using this code for risk adjustment.
MELAS is an acronym for Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes; document the specific manifestations present (seizures, strokes, encephalopathy) as additional codes to capture the full clinical picture.
HCC Buddy maintains structured V28 and V24 mapping, source-labeled coefficient references, and MEAT documentation criteria for E88.41 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •MELAS is an acronym for Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes; document the specific manifestations present (seizures, strokes, encephalopathy) as additional codes to capture the full clinical picture
- •This is a mitochondrial disorder code; verify documentation clearly states MELAS syndrome diagnosis and consider linking to related codes for seizures (G40.-), stroke-like episodes (I63.-), or encephalopathy (G93.4-) as applicable
Clinical Significance
MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes) syndrome is a specific mitochondrial disorder characterized by recurrent stroke-like episodes, seizures, lactic acidosis, and progressive neurological decline. It is a serious, life-limiting condition requiring multidisciplinary management.
Documentation Requirements
- ✓Confirmed MELAS diagnosis (clinical criteria plus genetic testing for mitochondrial DNA mutation, typically m.3243A>G)
- ✓Documentation of characteristic features (stroke-like episodes, seizures, lactic acidosis, myopathy)
- ✓Genetic testing results showing mitochondrial DNA mutation
- ✓Current neurological status and cognitive assessment
- ✓Serum and CSF lactate levels
- ✓Multi-system assessment (cardiac, endocrine, auditory, ophthalmologic)
- ✓Treatment plan (seizure management, metabolic support, coenzyme Q10, L-arginine)
Commonly Confused Codes
- •E88.42: MERRF syndrome: different mitochondrial syndrome with myoclonus epilepsy as primary feature
- •E88.40: Mitochondrial metabolism disorder, unspecified: less specific; use E88.41 when MELAS is confirmed
- •I63.9: Cerebral infarction, unspecified: MELAS stroke-like episodes are NOT true ischemic strokes
- •G40.909: Epilepsy, unspecified: seizures in MELAS are part of the syndrome, not a separate epilepsy diagnosis

